Perpetual LTD Viking Therapeutics, Inc. Transaction History
Perpetual LTD
- $10.2 Trillion
- Q1 2024
A detailed history of Perpetual LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Perpetual LTD holds 958,368 shares of VKTX stock, worth $64.2 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
958,368
Previous 958,368
-0.0%
Holding current value
$64.2 Million
Previous $78.6 Billion
-0.0%
% of portfolio
0.77%
Previous 0.77%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
428Shares Held
63.1MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$554 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$522 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$241 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$223 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$156 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.14B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...